FHIR © HL7.org | Server Home | FHIR Server FHIR Server 3.7.22-SNAPSHOT | FHIR Version n/a User: [n/a]

96050003: Cefpodoxime proxetil (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Antibacterial\Substance with beta-lactam structure and antibacterial mechanism of action (substance)\Cephalosporin (substance)\Third generation cephalosporin (substance)\Cefpodoxime proxetil

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Antibacterial\Substance with beta-lactam structure and antibacterial mechanism of action (substance)\Cephalosporin (substance)\Third generation cephalosporin (substance)\Cefpodoxime proxetil

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Amide\Lactam\Beta-lactam (substance)\Substance with beta-lactam structure and antibacterial mechanism of action (substance)\Cephalosporin (substance)\Third generation cephalosporin (substance)\Cefpodoxime proxetil

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

159090014 Cefpodoxime proxetil en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

840332017 Cefpodoxime proxetil (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

798901000172110 cefpodoxime proxétil fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Cefpodoxime proxetil	Is a	Product containing cefpodoxime (medicinal product)	false	Inferred relationship	Some
Cefpodoxime proxetil	Is a	Third generation cephalosporin (substance)	true	Inferred relationship	Some
Cefpodoxime proxetil	Is a	Cefpodoxime (substance)	false	Inferred relationship	Some
Cefpodoxime proxetil	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Cefpodoxime (substance)	true	Inferred relationship	Some
Cefpodoxime proxetil	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Antibacterial (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Cefpodoxime proxetil 50mg/5mL suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cefpodoxime proxetil	Inferred relationship	Some
Product containing precisely cefpodoxime 20 milligram/1 milliliter conventional release oral suspension (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cefpodoxime proxetil	Inferred relationship	Some
Cefpodoxime proxetil 100mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cefpodoxime proxetil	Inferred relationship	Some
Product containing precisely cefpodoxime proxetil 200 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cefpodoxime proxetil	Inferred relationship	Some
Cefpodoxime (as cefpodoxime proxetil) 100 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cefpodoxime proxetil	Inferred relationship	Some
Cefpodoxime 40mg/5mL pediatric suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cefpodoxime proxetil	Inferred relationship	Some
Cefpodoxime (as cefpodoxime proxetil) 100 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cefpodoxime proxetil	Inferred relationship	Some	1
Product containing precisely cefpodoxime proxetil 200 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cefpodoxime proxetil	Inferred relationship	Some	1
Product containing precisely cefpodoxime proxetil 200 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Cefpodoxime proxetil	Inferred relationship	Some	1
Product containing precisely cefpodoxime proxetil 200 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Cefpodoxime proxetil	Inferred relationship	Some	1
Cefpodoxime (as cefpodoxime proxetil) 100 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Cefpodoxime proxetil	Inferred relationship	Some	1
Product containing precisely cefpodoxime (as cefpodoxime proxetil) 8 milligram/1 milliliter conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Cefpodoxime proxetil	Inferred relationship	Some	1
Product containing precisely cefpodoxime (as cefpodoxime proxetil) 10 milligram/1 milliliter conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Cefpodoxime proxetil	Inferred relationship	Some	1
Cefpodoxime (as cefpodoxime proxetil) 200 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Cefpodoxime proxetil	Inferred relationship	Some	1
Product containing precisely cefpodoxime (as cefpodoxime proxetil) 100 milligram/1 each tablet for conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Cefpodoxime proxetil	Inferred relationship	Some	1
Product containing precisely cefpodoxime (as cefpodoxime proxetil) 20 milligram/1 milliliter conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Cefpodoxime proxetil	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
159090014	Cefpodoxime proxetil	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
840332017	Cefpodoxime proxetil (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
798901000172110	cefpodoxime proxétil	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module